Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces Boulardii
Status:
Unknown status
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
This study assesses the effect of quadruple therapy for H. pylori, with the addition of
probiotics Saccharomyces boulardii. In addition, he assesses whether this combination reduces
the frequency of adverse effects of eradication therapy, and whether it affects the
compliance.